Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs
Background: The reported prevalences of IgG autoantibodies (AAbs) to FcεRIα and IgE in sera from patients with chronic spontaneous urticaria (CSU) have varied, and these AAbs are also often observed in healthy control subjects. Regarding the histamine release activity of purified IgG from patients w...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893019300127 |
id |
doaj-d17fd1c812c740f0a4b398ba96e55c95 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Satoshi Izaki Shota Toyoshima Takahiro Endo Kazuko Kanegae Satoshi Nunomura Jun-ichi Kashiwakura Tomomi Sasaki-Sakamoto Ryosuke Nakamura Haruyo Akiyama Chisei Ra Koremasa Hayama Tadashi Terui Yoshimichi Okayama |
spellingShingle |
Satoshi Izaki Shota Toyoshima Takahiro Endo Kazuko Kanegae Satoshi Nunomura Jun-ichi Kashiwakura Tomomi Sasaki-Sakamoto Ryosuke Nakamura Haruyo Akiyama Chisei Ra Koremasa Hayama Tadashi Terui Yoshimichi Okayama Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs Allergology International |
author_facet |
Satoshi Izaki Shota Toyoshima Takahiro Endo Kazuko Kanegae Satoshi Nunomura Jun-ichi Kashiwakura Tomomi Sasaki-Sakamoto Ryosuke Nakamura Haruyo Akiyama Chisei Ra Koremasa Hayama Tadashi Terui Yoshimichi Okayama |
author_sort |
Satoshi Izaki |
title |
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs |
title_short |
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs |
title_full |
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs |
title_fullStr |
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs |
title_full_unstemmed |
Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs |
title_sort |
differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-ige autoantibodies (aabs) to induce fcεri crosslinking, as compared to anti-fcεriα aabs |
publisher |
Elsevier |
series |
Allergology International |
issn |
1323-8930 |
publishDate |
2019-07-01 |
description |
Background: The reported prevalences of IgG autoantibodies (AAbs) to FcεRIα and IgE in sera from patients with chronic spontaneous urticaria (CSU) have varied, and these AAbs are also often observed in healthy control subjects. Regarding the histamine release activity of purified IgG from patients with CSU, the number of examined patients has been small. Thus, we sought to determine the prevalence and FcεRI crosslinking ability of these AAbs in a large number of patients with CSU and non-atopic control (NC) subjects. Methods: We compared the concentrations of anti-IgE and anti-FcεRIα AAbs and the abilities of these AAbs to cause FcεRI aggregation in patients with CSU (n = 134) and NC subjects (n = 55) using ELISA and an in vitro elicitation test, respectively. Results: The concentration of anti-IgE AAbs was significantly different between the NC subjects and the CSU patients (P < 0.0001, cutoff value: 0.558 μg/mL), whereas the concentration of anti-FcεRIα AAbs was not. A significant difference in the duration of illness was noted between patients with lower and those with higher concentrations of anti-IgE AAbs relative to the cutoff value. The abilities of anti-IgE AAbs, but not anti-FcεRIα AAbs, to induce FcεRI crosslinking were significantly higher in CSU patients than in NC subjects (P = 0.0106). Conclusions: In the Japanese population of CSU patients studied, the ability of the anti-IgE AAbs to induce FcεRI crosslinking differed significantly between NC subjects and CSU patients, suggesting the involvement of anti-IgE AAbs in the pathogenesis of CSU in the Japanese population. Keywords: Autoantibody, Basophil/mast cell, FcεRIα, Immunoglobulin E, Urticaria |
url |
http://www.sciencedirect.com/science/article/pii/S1323893019300127 |
work_keys_str_mv |
AT satoshiizaki differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT shotatoyoshima differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT takahiroendo differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT kazukokanegae differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT satoshinunomura differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT junichikashiwakura differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT tomomisasakisakamoto differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT ryosukenakamura differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT haruyoakiyama differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT chiseira differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT koremasahayama differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT tadashiterui differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs AT yoshimichiokayama differentiationbetweencontrolsubjectsandpatientswithchronicspontaneousurticariabasedontheabilityofantiigeautoantibodiesaabstoinducefcericrosslinkingascomparedtoantifceriaaabs |
_version_ |
1725874656296042496 |
spelling |
doaj-d17fd1c812c740f0a4b398ba96e55c952020-11-24T21:52:49ZengElsevierAllergology International1323-89302019-07-01683342351Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbsSatoshi Izaki0Shota Toyoshima1Takahiro Endo2Kazuko Kanegae3Satoshi Nunomura4Jun-ichi Kashiwakura5Tomomi Sasaki-Sakamoto6Ryosuke Nakamura7Haruyo Akiyama8Chisei Ra9Koremasa Hayama10Tadashi Terui11Yoshimichi Okayama12Allergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Department of Dermatology, Nihon University School of Medicine, Tokyo, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Department of Dermatology, Nihon University School of Medicine, Tokyo, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, JapanDivision of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, JapanDepartment of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, JapanDivision of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, JapanDivision of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, JapanDepartment of Microbiology, Nihon University School of Medicine, Tokyo, Japan; Department of Clinical Laboratory, Asahi General Hospital, Chiba, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Department of Dermatology, Nihon University School of Medicine, Tokyo, JapanDepartment of Dermatology, Nihon University School of Medicine, Tokyo, JapanAllergy and Immunology Research Project Team, Nihon University School of Medicine, Tokyo, Japan; Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, Japan; Corresponding author. Allergy and Immunology Research Project Team, Center for Institutional Research and Medical Education, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.Background: The reported prevalences of IgG autoantibodies (AAbs) to FcεRIα and IgE in sera from patients with chronic spontaneous urticaria (CSU) have varied, and these AAbs are also often observed in healthy control subjects. Regarding the histamine release activity of purified IgG from patients with CSU, the number of examined patients has been small. Thus, we sought to determine the prevalence and FcεRI crosslinking ability of these AAbs in a large number of patients with CSU and non-atopic control (NC) subjects. Methods: We compared the concentrations of anti-IgE and anti-FcεRIα AAbs and the abilities of these AAbs to cause FcεRI aggregation in patients with CSU (n = 134) and NC subjects (n = 55) using ELISA and an in vitro elicitation test, respectively. Results: The concentration of anti-IgE AAbs was significantly different between the NC subjects and the CSU patients (P < 0.0001, cutoff value: 0.558 μg/mL), whereas the concentration of anti-FcεRIα AAbs was not. A significant difference in the duration of illness was noted between patients with lower and those with higher concentrations of anti-IgE AAbs relative to the cutoff value. The abilities of anti-IgE AAbs, but not anti-FcεRIα AAbs, to induce FcεRI crosslinking were significantly higher in CSU patients than in NC subjects (P = 0.0106). Conclusions: In the Japanese population of CSU patients studied, the ability of the anti-IgE AAbs to induce FcεRI crosslinking differed significantly between NC subjects and CSU patients, suggesting the involvement of anti-IgE AAbs in the pathogenesis of CSU in the Japanese population. Keywords: Autoantibody, Basophil/mast cell, FcεRIα, Immunoglobulin E, Urticariahttp://www.sciencedirect.com/science/article/pii/S1323893019300127 |